Related Experiment Video
Updated: Jul 30, 2025

09:16
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
Published on: October 30, 2016
11.3K
Virosome: An engineered virus for vaccine delivery
Hasan Ali1, Md Akbar2, Babar Iqbal3
1Department of Pharmacy, Meerut Institute of Technology, National Highway-58, Meerut 250103, Uttar Pradesh, India.
Summary
Virosome-based vaccines represent a next-generation immunization approach, offering a balance between efficacy and tolerability. This review explores virosomes
Area of Science:
- Immunology
- Vaccinology
- Nanotechnology
Background:
- Conventional vaccine delivery methods have limitations.
- Novel vaccine delivery systems like micro-particles, liposomes, and nanoparticles are under investigation.
- Virosomes offer a promising alternative for vaccine development.
Purpose of the Study:
- To provide a comprehensive overview of virosome-based vaccines.
- To discuss the structure, composition, formulation, and development of virosomes.
- To highlight the advantages, immune interactions, clinical status, and future prospects of virosomes in immunization.
Main Methods:
- Review of existing literature on virosomes and vaccine delivery.
- Analysis of virosome structure, function, and immune response.
- Examination of clinical trial data and patent information related to virosomes.
- Discussion of recent advances and research in virosome technology.
Main Results:
- Virosomes demonstrate versatility as vaccine adjuvants and delivery vehicles for various molecules.
- They offer a favorable balance between efficacy and tolerability due to their immune stimulation mechanism.
- Virosomes show potential for drug targeting applications.
- Current clinical status and patent landscape indicate growing interest and application.
Conclusions:
- Virosome-based vaccines represent a significant advancement in immunization technology.
- Their unique properties offer enhanced efficacy, safety, and tolerability.
- Further research and clinical development are expected to expand their applications in vaccinology and drug delivery.
Related Concept Videos
Introduction to Virus
102
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
102
Viral Structure
62.8K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.8K
Retrovirus Life Cycles
46.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.3K
Microorganisms in Medicine and Therapeutics
78
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
78

